The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 20,801–20,900 of 31,469
Glucose transporter 1 deficiency syndrome: nutritional and growth pattern phenotypes at diagnosis
Bertoli, S., Masnada, S., Amicis, R. S. D., et al. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0662-z · Cited by 10
Zhu, W., Deng, C., Xuan, L. P., Dai, H. J., Zhao, Z. Y., Wang, T. G., Li, M., Lu, J. L., Xu, Y., Chen, Y. H., et al. (2020) · PubMed · doi:10.3967/bes2020.031 · Cited by 10
Early postnatal stress impairs insulin secretion in response to psychological stress in adult rats
Zardooz, H., Sadeghimahalli, F., & Khodagholi, F. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01291-9 · Cited by 11
Tobar-Bernal, F. A., Zamudio, S., & Quevedo-Corona, L. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420000501 · Cited by 9
Population insulin sensitivity from sparsely sampled oral glucose tolerance tests
Stefanovski, D., Vellanki, P., Smiley, D. D., Umpierrez, G. E., & Boston, R. C. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154298 · Cited by 11
Ma, N., Xu, N., Yin, D., Liu, W. W., Wu, M., & Cheng, X. (2020) · Medicine · doi:10.1097/md.0000000000020737 · Cited by 10
Roche, J., Corgosinho, F. C., Isacco, L., Scheuermaier, K. D., Pereira, B., Gillet, V., Moreira, G. A., Pradella-Hallinan, M. L. D. C., Tufik, S., de Mello, M. T., et al. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.06.030 · Cited by 11
Ore, A., Ugbaja, R. N., Adeogun, A. I., et al. (2020) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000071 · Cited by 10
Bakhtiyari, A., Haghani, K., Bakhtiyari, S., Zaimy, M. A., Noori-Zadeh, A., Gheysarzadeh, A., Darabi, S., Seidkhani‐Nahal, A., Amraei, M., & Alipourfard, I. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200713091827 · Cited by 10
Al-ghamdi, H. A., Fayez, F. F. A., Bima, A. I. H., Khawaji, T. M., & Elsamanoudy, A. Z. (2020) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2020.07.003 · Cited by 10
Adamczewska, K., Adamczewski, Z., Łupińska, A., Lewiñski, A., & Stawerska, R. (2020) · Molecules · doi:10.3390/molecules25173912 · Cited by 13
Ikeda, A., Steptoe, A., Brunner, E. J., Maruyama, K., Tomooka, K., Kato, T., Miyoshi, N., Nishioka, S., Saito, I., & Tanigawa, T. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.53926 · Cited by 10
Talib, A., Roebroek, Y. G. M., Paulus, G. F., van Loo, K., Winkens, B., Bouvy, N. D., & van Heurn, E. L. W. (2020) · Pediatric Cardiology · doi:10.1007/s00246-020-02487-9 · Cited by 10
Chang, Y., Fan, H., Lim, P., Chuang, S., & Hsu, C. (2020) · Diabetic Medicine · doi:10.1111/dme.14436 · Cited by 10
Mahamad, A. T., Miaffo, D., Kamani, S. L. P., Mahamat, O., Kamanyi, A., & Ngnokam, S. L. W. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00687-x · Cited by 12
Eshima, H., Tamura, Y., Kakehi, S., Kakigi, R., Kawamori, R., & Watada, H. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00218.2020 · Cited by 11
Utility of quantitative ultrasound in community screening for hepatic steatosis
Chang, T.-Y., Chang, S., Lin, Y.-H., Ho, W., Wang, C.-Y., Jeng, W., Wan, Y., & Tsui, P. (2020) · Ultrasonics · doi:10.1016/j.ultras.2020.106329 · Cited by 10
Association of FADS2 rs174575 gene polymorphism and insulin resistance in type 2 diabetes mellitus
Shetty, S. S., Kumari, S., Devi, H. R. N., et al. (2020) · African Health Sciences · doi:10.4314/ahs.v20i4.30 · Cited by 10
Gentile, M., Iannuzzo, G., Simeon, V., et al. (2020) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2020.1858537 · Cited by 10
Verduci, E., Banderali, G., Profio, E. D., Vizzuso, S., Zuccotti, G., & Radaelli, G. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-020-00537-w · Cited by 10
Ryckeghem, L. V., Keytsman, C., Verboven, K., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa007 · Cited by 10
Lin, Y., Chang, P., Liu, K., et al. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.01.004 · Cited by 10
Nishida, Y., Nishijima, K., Yamada, Y., Tanaka, H., Matsumoto, A., Fan, J., Uda, Y., Tomatsu, H., Yamamoto, H., Kami, K., et al. (2021) · Metabolomics · doi:10.1007/s11306-021-01777-4 · Cited by 12
de Lima, T. R., González‐Chica, D. A., Sui, X., et al. (2021) · European Journal of Sport Science · doi:10.1080/17461391.2021.1902571 · Cited by 10
El‐Magd, N. F. A., El‐Mesery, M., El-Karef, A. A., et al. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13693 · Cited by 10
Mohammad, J. A., Fathi, Z. H., & Allwsh, T. A. (2021) · Pharmacia · doi:10.3897/pharmacia.68.e63449 · Cited by 10
Hua, M., Su, H., Lai, M., Yao, T., Tsai, M., Liao, S., Lai, S., & Huang, J. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.628496 · Cited by 10
Carosi, G., Mangone, A., Sala, E., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0024 · Cited by 10
Bedair, R. N., Magour, G. M., Ooda, S. A., et al. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-020-00069-1 · Cited by 10
Guan, L., Fan, P., Liu, X., Zhou, M., Wu, Y., Liu, R., Liu, Y., & Bai, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.690229 · Cited by 10
Mahdavifard, S., & Nakhjavani, M. (2021) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_319_19 · Cited by 10
Cignarelli, A., Ciavarella, A., Barbaro, M. P. F., Kounaki, S., Trani, A. D., Falcone, V. A., Quaranta, V. N., Natalicchio, A., Laviola, L., Resta, O., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01602-8 · Cited by 10
Kechribari, I., Kontogianni, M. D., Georgoulis, M., Lamprou, K., Vagiakis, E., & Yiannakouris, N. (2021) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12933 · Cited by 10
Hong, J., Shin, W., Lee, J.-W., & Kim, Y. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0011 · Cited by 10
Júnior, J. R. D. F., Ribeiro, I. B., de Moura, D. T. H., Sagae, V. M. T., de Souza, G. M. V., de Oliveira, G. H. P., Sánchez‐Luna, S. A., de Souza, T. F., Moura, E. T. H. D., de Oliveira, C. P. M. S., et al. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i7.815 · Cited by 10
Furino, V. D. O., Alves, J. M., Marine, D. A., Sene‐Fiorese, M., Rodrigues, C. N. D. S., Arrais-Lima, C., Mattiello, S. M., de Castro, C. A., Borra, R. C., Rocha, M. C., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.564963 · Cited by 10
Independent Dose–Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease
Lu, C., Lee, Y.-C., Chiang, C., Chang, H., Yang, W., & Huang, K. (2021) · Nutrients · doi:10.3390/nu13092928 · Cited by 10
Ahmadabadi, F., Nakhaei, H., Mogharnasi, M., & Huang, C. (2021) · Physiology International · doi:10.1556/2060.2021.00182 · Cited by 10
Xie, K., Chien, S., Tan, B. C., & Chen, Y. (2021) · The FASEB Journal · doi:10.1096/fj.202100265rr · Cited by 10
T Cell-based RAS Activity and Insulin Levels in Obese Subjects with Low Grade Inflammation
Coppo, M., Bandinelli, M., Chiostri, M., Modesti, P. A., Poggesi, L., & Boddi, M. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.09.003 · Cited by 11
Ibrahim, W. S., Ahmed, H., Mahmoud, A. A. A., Mahmoud, M. F., & Ibrahim, I. A. A. E.-H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120055 · Cited by 10
Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population
Gong, S., Han, X., Li, M., Cai, X., Liu, W., Luo, Y., Zhang, S.-M., Zhou, L., Ma, Y., Huang, X., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.677130 · Cited by 10
CRUZ-VILLANUEVA, S. R., Ramírez‐Nava, J., MORENO-LUNA, J. A., Ureña, K. G. C., Espín-Iturbe, L. T., Sánchez‐Otero, M. G., Quintana‐Castro, R., & Alexander-Aguilera, A. (2021) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.67.292 · Cited by 10
Selenius, J. S., Silveira, P. P., Salonen, M. K., Kautiainen, H., von Bonsdorff, M. B., Kajantie, E., Lahti, J. M. T., Eriksson, J. G., & Wasenius, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-00631-w · Cited by 11
Raets, L., Marie, V., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.781384 · Cited by 11
Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients
Gavril, O. I., Arhire, L. I., Gavril, R. S., Zota, I. M., Gherasim, A., Niță, O., Drugescu, A., Oprescu, A. C., Eşanu, I., Mitu, F., et al. (2021) · Medicina · doi:10.3390/medicina57111249 · Cited by 10
Kim, H. M., & Lee, Y. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1087 · Cited by 10
Vales‐Villamarín, C., de Dios, O., Pérez-Nadador, I., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.763853 · Cited by 10
Khan, U. I., McGinn, A. P., Isasi, C. R., Groisman-Perelstein, A. E., Diamantis, P. M., Ginsberg, M. S., & Wylie‐Rosett, J. (2015) · Childhood Obesity · doi:10.1089/chi.2014.0112 · Cited by 10
Calza, L., Borderi, M., Colangeli, V., et al. (2021) · AIDS · doi:10.1097/qad.0000000000003063 · Cited by 10
Ahn, M. B., Kim, S.-K., Kim, S. H., Cho, W. K., Suh, J., Cho, K., Suh, B., & Jung, M. H. (2021) · Children · doi:10.3390/children8121155 · Cited by 11
Berezin, A. A., Fushtey, I. M., & Berezin, A. Е. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9010023 · Cited by 10
Samaha, M. M., Helal, M. G., El‐Sherbiny, M., Said, E., & Salem, H. A. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103806 · Cited by 10
Şahin, K., Orhan, C., Küçük, O., Tuzcu, M., Şahin, N., Özercan, İ. H., Sylla, S., Ojalvo, S. P., & Komorowski, J. R. (2022) · Food Chemistry Molecular Sciences · doi:10.1016/j.fochms.2022.100081 · Cited by 10
An, S., Li, Y., Jia, X., Yang, Y., Jia, X., Jia, X., & Xue, W. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22988 · Cited by 12
Hanaoka, B. Y., Zhao, J., Heitman, K. N., Khan, F., Jarjour, W. N., Volek, J. S., Brock, G. N., & Gower, B. A. (2022) · JCSM Clinical Reports · doi:10.1002/crt2.45 · Cited by 10
Ma, B., Yang, P., Gao, J., Du, L., Sheng, C., Usman, T., Wang, X., & Qu, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.824193 · Cited by 11
Guagnano, M. T., D’Ardes, D., Rossi, I., Santilli, F., Schiavone, C., Bucci, M., & Cipollone, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102759 · Cited by 10
Jeans, M., Vandyousefi, S., Landry, M. J., Leidy, H. J., Gray, M. J., Bray, M. S., Widen, E. M., & Davis, J. N. (2022) · Nutrients · doi:10.3390/nu14112320 · Cited by 11
Frequency of Dyslipidemia and Associated Risk Factors Among Obese Children and Adolescents in Turkey
Dündar, İ., & Akıncı, A. (2022) · Iranian Journal of Pediatrics · doi:10.5812/ijp-122937 · Cited by 14
Ferrannini, G., Bacquer, D. D., Erlund, I., Gyberg, V., Kotseva, K., Mellbin, L., Norhammar, A., Schnell, O., Tuomilehto, J. O., Vihervaara, T., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0272 · Cited by 11
Yang, S.-E., Lin, Y. F., Liao, J., Chen, J., Chen, C., Chen, C.-I., Hsu, S., & Song, T. (2022) · The Chinese Journal of Physiology · doi:10.4103/cjp.cjp_88_21 · Cited by 10
Milani, N., Bonakdaran, S., Khorasani, Z. M., Hosseinzadeh, M., & Kabiri, M. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220426090324 · Cited by 10
Stewart, J. W., Arneson, A. G., Byrd, M. K. H., Negrón‐Pérez, V. M., Newberne, H. M., White, R. R., El‐Kadi, S. W., Ealy, A. D., Rhoads, R. P., & Rhoads, M. L. (2022) · Journal of Dairy Science · doi:10.3168/jds.2022-21922 · Cited by 11
HOMA-IR index in non-diabetic patient, a reliable method for early diagnosis of liver steatosis.
Motamed, B., Vajargah, M. K., Kalantari, S., & Shafaghi, A. (2022) · PubMed Central · doi:10.22088/cjim.13.3.519 · Cited by 10
The association of serum vitamin D with incident diabetes in an African American population
Joseph, J. J., Langan, S. J., Lunyera, J., Kluwe, B., Williams, A., Chen, H., Sachs, M. C., Hairston, K. G., Bertoni, A. G., Hsueh, W. A., et al. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00220-4 · Cited by 9
Lu, K., He, Y., Wu, C., & Bao, J. (2022) · Nutrients · doi:10.3390/nu14214620 · Cited by 10
Inactive matrix Gla protein in relation to diabetic retinopathy in type 2 diabetes
Adel, H., Fawzy, O., Mahmoud, E., et al. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01180-3 · Cited by 10
Lin, X. L., Li, Q., Zhao, D., et al. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231152823 · Cited by 10
Xiu-ping, B., Du, W.-J., Xing, H.-B., Yang, G., & Bai, R. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00989-z · Cited by 12
Siqueira, J. S., Nakandakare-Maia, E. T., Vieira, T. A., Palacio, T. L. N., Grandini, N. A., Belin, M. A. F., Nai, G. A., Moreto, F., Altomare, A., Baron, G., et al. (2023) · Livers · doi:10.3390/livers3020017 · Cited by 11
Ilkay, H. O., Karabulut, D., Kamacı, G., Mehmetbeyoğlu, E., Kaymak, E., Kisioglu, B., Çiçek, B., & Akyol, A. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3603 · Cited by 10
Long, H., Lin, Y., Liu, M.-J., Liang, L., & Zeng, Z. H. (2013) · PubMed · doi:10.3275/8946 · Cited by 10
Yoon, J. W., Jung, H. S., Jang, J. Y., Kim, M. J., Kim, J. H., Ohn, J. H., Kim, J. H., Lee, H. M., Kim, H., Lee, K. B., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x682440 · Cited by 10
Síndrome de ovario poliquístico. diagnóstico y manejo
Sir, P. T., Preisler, R. J., & Magendzo, N. A. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70229-3 · Cited by 10
Martínez-Alvarado, M. R., Juárez-Rojas, J. G., Medina-Urrutia, A. X., Cardoso-Saldaña, G. C., González-Salazar, M. D. C., Posadas‐Sánchez, R., Galarza, E. J., Mendoza-Peŕez, E., Vargas‐Alarcón, G., & Posadas‐Romero, C. (2014) · PubMed · Cited by 10
Zhang, R., Jiang, F., Hu, C., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03758.x · Cited by 10
Sánchez, R. J., Estrada, P., del Peso, G., Grande, C., Díez, J. J., Iglesias, P., González, E., Aguilar-Rodríguez, A., Selgas, R., & Bajo, M. A. (2013) · PubMed · doi:10.3265/nefrologia.pre2012.nov.11430 · Cited by 11
Acanthosis nigricans as an indicator of insulin resistance in Chilean adult population.
Pinheiro, A. C., Rojas, P., Fernando Carrasco, N., Gómez, P., Mayas, N., & Morales, I. (2011) · PubMed · doi:10.1590/s0212-16112011000500003 · Cited by 10
Pescatello, L. S. (2008) · The Application of Clinical Genetics · doi:10.2147/tacg.s3813 · Cited by 10
Wall motion velocities of ascending aorta measured by tissue Doppler imaging in obese children
Paç, F. A., Guray, Y. A., & Polat, T. B. (2010) · Pediatrics International · doi:10.1111/j.1442-200x.2010.03173.x · Cited by 10
The role of osteocalcin in the connection of bone and glucose metabolism in humans
Buday, B., Kulcsár, E., Literáti-Nagy, B., Horváth, T., Vitai, M., Vecsei, I., Bezzegh, K., Kiss, J., Péterfai, É., Koltay, L., et al. (2008) · Orvosi Hetilap · doi:10.1556/oh.2008.28518 · Cited by 10
Florêncio, T. M. D. M. T., Bueno, N. B., Clemente, A. P. G., Albuquerque, F. C. A., Britto, R. P. D. A., Ferriolli, E., & Sawaya, A. L. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001816 · Cited by 11
Insulin sensitivity and secretion in youth onset type 2 diabetes with and without visceral adiposity
Amutha, A., Ali, M. K., Ranjit Unnikrishnan, I., Anjana, R. M., Ranjani, H., Gokulakrishnan, K., Mohan, V., & Narayan, K. M. V. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.018 · Cited by 10
MOREUIL, C. D., Kerspern, H., Moigne, E. L., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0048 · Cited by 10
Morisset, A., Tardio, V., Weisnagel, J., Lemieux, S., Bergeron, J., & Gagnon, C. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0159 · Cited by 10
Vigneault, J., Lemieux, S., Garneau, V., Weisnagel, S. J., Tchernof, A., & Robitaille, J. (2014) · Obesity · doi:10.1002/oby.20940 · Cited by 10
Clemente‐Postigo, M., Queipo‐Ortuño, M. I., Valdivielso, P., Tinahones, F. J., & Cardona, F. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.08.014 · Cited by 10
Hitsumoto, T., Takahashi, M., Iizuka, T., & Shirai, K. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e547 · Cited by 10
C‐reactive protein and incident diabetes in patients with arterial disease
Verhagen, S. N., Wassink, A. M. J., van der Graaf, Y., Visseren, F. L. J., & SMART Study Group (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12142 · Cited by 10
Park, S. K., Choi, W. J., Oh, C., Kim, M., Ham, W. T., Choi, J., & Ryoo, J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.022 · Cited by 10
Crook, M. A., Ch'ng, S. I., Lumb, P. J., et al. (2001) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456320103800506 · Cited by 10
Manu, P., Correll, C. U., Wampers, M., van Winkel, R., Yu, W., Mitchell, A. J., & Binder, M. D. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.002 · Cited by 10
Interrelationship between coagulation factor VII and obesity in diabetes mellitus (type 2)
Karatela, R. A., & Sainani, G. S. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.02.018 · Cited by 10
de Luis, D. A., Aller, R., Izaola, O., et al. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000346800 · Cited by 10
Sainani, G. S., & Karatela, R. A. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0097 · Cited by 10
Glycemic Index and Glucose Utilization of Rice Vermicelli in Healthy Subjects
Sato, S., Fukumura, K., Nishiyama, A., Kanamoto, I., Inoue, Y., & Konishi, T. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1385 · Cited by 10
Iuliano, A. D., Feingold, E., Wahed, A. S., et al. (2009) · Intervirology · doi:10.1159/000214380 · Cited by 10
Rennings, A. J. M., Rüssel, F. G. M., Li, Y., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.360 · Cited by 10
Iwao, T., Sakai, K., & Ando, E. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.0337 · Cited by 10
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
